Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: placebo; Drug: ipratropium bromide
Sponsors: Boehringer Ingelheim Pharmaceuticals; Boehringer Ingelheim Pharmaceuticals
Not yet recruiting – verified September 2013
View full post on ClinicalTrials.gov: asthma | received in the last 14 days